Suren Krishnan
Royal Adelaide Hospital, Deakin University, University of Adelaide
Papers
16
Total Citations
712
H-Index
9
About
Dr. Suren Krishnan is a leading head and neck surgeon whose pioneering work has reshaped the landscape of oropharyngeal cancer treatment. His primary research focuses on minimally invasive surgical techniques, particularly transoral robotic surgery (TORS), and their role in improving patient outcomes. Dr. Krishnan is best known as the lead investigator of the landmark ORATOR trial, which directly compared radiotherapy to TORS for oropharyngeal squamous cell carcinoma. The initial results, published in 2019, have garnered over 458 citations, fundamentally influencing clinical decision-making and sparking global debate on optimal treatment paradigms. His work extends to refining diagnostic techniques, such as using TORS for base of tongue mucosectomy in cancers of unknown primary, and evaluating novel robotic platforms like the Medrobotic Flex® system. With a career spanning over a decade of high-impact publications, including final ORATOR results and studies on functional outcomes after total laryngectomy, Dr. Krishnan’s contributions have not only advanced surgical precision but also provided critical evidence for tailoring curative-intent therapies, making him a pivotal figure in modern head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Transoral robotic excision of a lingual thyroglossal duct cyst17 citations · 2017
- 9
- 10